invasion (VPI), which denotes the tumor's breach of the elastic layer or reaching the surface of the visceral pleura, stands as a pivotal factor that impacts the prognosis of patients with nonsmall cell lung cancer (NSCLC) and directly influences the pathological st...
These examinations and tests help to determine the stage of cancer. Staging is important because lung cancer treatment depends on the stage of cancer. Examinations and tests used to detect the spread of cancer may include the following: Blood tests: Complete blood count (CBC) (provides ...
Stage 2non-small cell lung cancer(NSCLC) is localized cancer that has not spread beyond one lung or the locallymph nodeson the same side of the chest. Any lung cancer diagnosis is serious, but being in thisearly stagemeans your disease is very treatable, and your chances for a long-term...
Multiple factors have been reported as affecting the prognosis, and they affect the therapeutic outcomes of stage I non-small-cell lung cancer (NSCLC) pati... W Meng,J Zhao,P Yi,... - 《World Journal of Surgery》 被引量: 37发表: 2009年 Evaluation of pure ground glass pulmonary nodule:...
Staging of Small Cell Lung Cancer A two-stage classification developed by the Veterans Administration Lung Cancer Study Group is widely accepted for staging of SCLC. When the entire tumor is confined to thethoraxand can be included in a single radiation therapy port, the disease is defined...
Prognosis was correlated with disease extent. Surgical resection as well as limited stage disease thus both contributed to survival. Poor performance status, reduced concentration, and raised values for serum dehydrogenase were significantly associated with a reduced duration of survival in both stages. ...
Objective This study aimed to construct a nomogram to effectively predict the overall survival (OS) of patients with stage IB non-small-cell lung cancer (NSCLC).Methods In total, 5513 patients with stage IB NSCLC were extracted from the Surveillance, Epidemiology, and End Results (SEER) data...
Outcome by Pretreatment Characteristics Table 2. Survival Rates According to Clinical Stage for Non-Small Cell Lung Cancer Treated With Radiation Therapy Clinical stage llP%) All Performance If%) patients status 0-1 IIIA(%) IIIB(o/~) No. of patients Survival (yr) 1 1.5 2 3 40 72 50 35...
Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by an exceptionally high proliferative rate, strong predilection for early metastasis and poor prognosis. SCLC is strongly associated with exposure to tobacco carcinogens. Most patients have metastatic disease at dia...
In the 1997 revision of the TNM staging system for lung cancer, patients with T3N0M0 disease were moved from stage IIIA to stage IIB since these patients have a better prognosis. Despite this modification, the local lymph node metastasis remained the most important prognostic factor in patients...